VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NBIX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NBIXNeurocrine Biosciences, Inc.
$177.49$17.8B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksNBIXQuarterly Financials

Neurocrine Biosciences, Inc. (NBIX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Neurocrine Biosciences, Inc. (NBIX) quarterly income statement — complete revenue, gross profit & net income history

NBIX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue814.5M805.5M794.9M687.5M572.6M627.7M622.1M590.2M515.3M515.2M498.8M452.7M420.4M412M387.9M378.2M310.6M312M296M288.9M
Revenue Growth %42.25%28.33%27.78%16.49%11.12%21.84%24.72%30.37%22.57%25.05%28.59%19.7%35.35%32.05%31.05%30.91%31.28%25.86%14.51%-4.46%
Cost of Goods Sold13.8M17.6M14M11.3M9.2M9.3M8M9.2M7.5M8.5M11.2M11.5M8.5M7.7M6.1M4.8M4.6M4.1M4.2M3.1M
COGS % of Revenue1.69%2.19%1.76%1.64%1.61%1.48%1.29%1.56%1.46%1.65%2.25%2.54%2.02%1.87%1.57%1.27%1.48%1.31%1.42%1.07%
Gross Profit800.7M787.9M780.9M676.2M563.4M618.4M614.1M581M507.8M506.7M487.6M441.2M411.9M404.3M381.8M373.4M306M307.9M291.8M285.8M
Gross Margin %98.31%97.81%98.24%98.36%98.39%98.52%98.71%98.44%98.54%98.35%97.75%97.46%97.98%98.13%98.43%98.73%98.52%98.69%98.58%98.93%
Gross Profit Growth %42.12%27.41%27.16%16.39%10.95%22.04%25.94%31.69%23.28%25.33%27.71%18.16%34.61%31.31%30.84%30.65%30.94%25.67%14.07%-4.73%
Operating Expenses614.7M577M541.9M530.6M539.8M476.4M430.3M435.6M408.5M356.4M346.4M367.6M526.1M300.9M294M318.7M302.9M344.2M247.3M223M
OpEx % of Revenue75.47%71.63%68.17%77.18%94.27%75.9%69.17%73.81%79.27%69.18%69.45%81.2%125.14%73.03%75.79%84.27%97.52%110.32%83.55%77.19%
Selling, General & Admin318.5M301.8M291.6M286.3M276.5M287.8M234.3M242M243.1M218.9M204.2M221.8M242.7M182.9M186.3M182.8M200.7M156.5M154.6M143.2M
SG&A % of Revenue39.1%37.47%36.68%41.64%48.29%45.85%37.66%41%47.18%42.49%40.94%48.99%57.73%44.39%48.03%48.33%64.62%50.16%52.23%49.57%
Research & Development296.2M258.2M250M244.3M263.2M185.6M195M191.1M159.4M137.5M142.2M145.8M139.5M118M107.7M135.9M102.2M87.4M92.7M74.8M
R&D % of Revenue36.37%32.05%31.45%35.53%45.97%29.57%31.35%32.38%30.93%26.69%28.51%32.21%33.18%28.64%27.76%35.93%32.9%28.01%31.32%25.89%
Other Operating Expenses01000K300K0100K1000K1000K1000K1000K0001000K00001000K01000K
Operating Income193.4M210.9M239M145.6M23.6M142M183.8M145.4M99.3M150.3M141.2M73.6M-114.2M103.4M87.8M54.7M3.1M-36.3M44.5M62.8M
Operating Margin %23.74%26.18%30.07%21.18%4.12%22.62%29.55%24.64%19.27%29.17%28.31%16.26%-27.16%25.1%22.63%14.46%1%-11.63%15.03%21.74%
Operating Income Growth %719.49%48.52%30.03%0.14%-76.23%-5.52%30.17%97.55%186.95%45.36%60.82%34.55%-3783.87%384.85%97.3%-12.9%-90.16%-150.56%200.45%-18.02%
EBITDA193.4M218.4M246.7M152.9M31.2M149.1M190.3M152.7M105.5M156M146.7M78.7M-109.2M107.8M91.8M58.6M6.4M-33.3M47.3M65.4M
EBITDA Margin %23.74%27.11%31.04%22.24%5.45%23.75%30.59%25.87%20.47%30.28%29.41%17.38%-25.98%26.16%23.67%15.49%2.06%-10.67%15.98%22.64%
EBITDA Growth %519.87%46.48%29.64%0.13%-70.43%-4.42%29.72%94.03%196.61%44.71%59.8%34.3%-1806.25%423.72%94.08%-10.4%-81.18%-145%212.35%-16.9%
D&A (Non-Cash Add-back)07.5M7.7M7.3M7.6M7.1M6.5M7.3M6.2M5.7M5.5M5.1M5M4.4M4M3.9M3.3M3M2.8M2.6M
EBIT0227.9M291.8M145.6M23.7M174.6M184.8M147.9M105.3M199.3M141.2M121.6M-102.2M119M99.1M-21.1M24M-7.2M37.1M63.7M
Net Interest Income0-42.8M22.2M20.6M000-49.7M-1.1M-1.1M-1.1M10.7M-1.1M-1.1M-1.2M-2.2M-2.6M-6.6M-6.6M-6.2M
Interest Income0-42.8M22.2M20.6M000000012M00000000
Interest Expense000000049.7M1.1M1.1M1.1M1.3M1.1M1.1M1.2M2.2M2.6M6.6M6.6M6.2M
Other Income/Expense53.4M28.5M52.8M13.9M-8.9M20.6M6.5M-46.8M-64.8M47.9M-25.6M48M10.9M14.5M10.1M-78M18.3M22.5M-14M-5.3M
Pretax Income246.8M239.4M291.8M159.5M14.7M162.6M190.3M98.6M34.5M198.2M115.6M121.6M-103.3M117.9M97.9M-23.3M21.4M-13.8M30.5M57.5M
Pretax Margin %30.3%29.72%36.71%23.2%2.57%25.9%30.59%16.71%6.7%38.47%23.18%26.86%-24.57%28.62%25.24%-6.16%6.89%-4.42%10.3%19.9%
Income Tax48.9M85.7M82.3M52M6.8M59.5M60.5M33.6M-8.9M50.5M32.5M26.1M-26.7M28.9M29.4M-6.4M7.5M-6.5M8M15.2M
Effective Tax Rate %19.81%35.8%28.2%32.6%46.26%36.59%31.79%34.08%-25.8%25.48%28.11%21.46%25.85%24.51%30.03%27.47%35.05%47.1%26.23%26.43%
Net Income197.9M153.7M209.5M107.5M7.9M103.1M129.8M65M43.4M147.7M83.1M95.5M-76.6M89M68.5M-16.9M13.9M-7.3M22.5M42.3M
Net Margin %24.3%19.08%26.36%15.64%1.38%16.43%20.86%11.01%8.42%28.67%16.66%21.1%-18.22%21.6%17.66%-4.47%4.48%-2.34%7.6%14.64%
Net Income Growth %2405.06%49.08%61.4%65.38%-81.8%-30.2%56.2%-31.94%156.66%65.96%21.31%665.09%-651.08%1319.18%204.44%-139.95%-56.7%-102.1%139.06%-46.86%
Net Income (Continuing)197.9M153.7M209.5M107.5M7.9M103.1M129.8M65M43.4M147.7M83.1M95.5M-76.6M89M68.5M-16.9M13.9M-7.3M22.5M42.3M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)1.911.482.041.060.081.001.240.630.421.440.820.95-0.790.880.69-0.180.14-0.080.230.43
EPS Growth %2287.5%48%64.52%68.25%-80.95%-30.56%51.22%-33.68%153.16%63.64%18.84%627.78%-664.29%1244.34%200%-141.86%-57.58%-102.15%137.1%-46.91%
EPS (Basic)1.971.542.111.090.081.031.280.640.431.500.850.98-0.790.920.72-0.180.15-0.080.240.45
Diluted Shares Outstanding103.4M102.5M102.5M101M102.5M102.9M104.3M103.9M103.6M102.3M101.1M100.2M97.1M100.8M99M95.6M97.6M94.9M97.7M97.7M
Basic Shares Outstanding100.5M99.5M99.4M99M99.7M100M101.1M100.8M99.8M98.4M97.9M97.6M97.1M96.3M95.8M95.6M95.3M94.9M94.7M94.6M
Dividend Payout Ratio--------------------